These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14709973)

  • 21. An Unreported Cause of Intrathecal Baclofen Withdrawal Symptoms in a Woman With Spastic Cerebral Palsy Who Received Intrathecal Gablofen.
    Duraski SA; Sayyad A
    J Neurosci Nurs; 2018 Apr; 50(2):116-119. PubMed ID: 29521737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. AACPDM Treatment Outcomes Committee Review Panel.
    Butler C; Campbell S
    Dev Med Child Neurol; 2000 Sep; 42(9):634-45. PubMed ID: 11034458
    [No Abstract]   [Full Text] [Related]  

  • 23. Experience with external pump trial prior to implantation for intrathecal baclofen in ambulatory patients with spastic cerebral palsy.
    Bleyenheuft C; Filipetti P; Caldas C; Lejeune T
    Neurophysiol Clin; 2007; 37(1):23-8. PubMed ID: 17418354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of antispastic drugs on motor reflexes and voluntary muscle contraction in incomplete spinal cord injury.
    Chu VW; Hornby TG; Schmit BD
    Arch Phys Med Rehabil; 2014 Apr; 95(4):622-32. PubMed ID: 24269485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of continuous intrathecal baclofen on sitting in children with severe cerebral palsy.
    Gray N; Vloeberghs M
    Eur J Paediatr Neurol; 2014 Jan; 18(1):45-9. PubMed ID: 24100173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance and complications associated with the synchromed 10-ml infusion pump for intrathecal baclofen administration in children.
    Albright AL; Awaad Y; Muhonen M; Boydston WR; Gilmartin R; Krach LE; Turner M; Zidek KA; Wright E; Swift D; Bloom K
    J Neurosurg; 2004 Aug; 101(1 Suppl):64-8. PubMed ID: 16206974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidimensional assessment of motor function in a child with cerebral palsy following intrathecal administration of baclofen.
    Almeida GL; Campbell SK; Girolami GL; Penn RD; Corcos DM
    Phys Ther; 1997 Jul; 77(7):751-64. PubMed ID: 9225847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled study of the effects of continuous intrathecal baclofen infusion in non-ambulant children with cerebral palsy.
    Morton RE; Gray N; Vloeberghs M
    Dev Med Child Neurol; 2011 Aug; 53(8):736-41. PubMed ID: 21707598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrathecal baclofen.
    Russman BS
    Dev Med Child Neurol; 2010 Jul; 52(7):601-2. PubMed ID: 19832881
    [No Abstract]   [Full Text] [Related]  

  • 30. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy.
    Meythaler JM; Guin-Renfroe S; Law C; Grabb P; Hadley MN
    Arch Phys Med Rehabil; 2001 Feb; 82(2):155-61. PubMed ID: 11239304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hip status in cerebral palsy after one year of continuous intrathecal baclofen infusion.
    Krach LE; Kriel RL; Gilmartin RC; Swift DM; Storrs BB; Abbott R; Ward JD; Bloom KK; Brooks WH; Madsen JR; McLaughlin JF; Nadell JM
    Pediatr Neurol; 2004 Mar; 30(3):163-8. PubMed ID: 15033197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occurrence of adverse events in long-term intrathecal baclofen infusion: a 1-year follow-up study of 158 adults.
    Borrini L; Bensmail D; Thiebaut JB; Hugeron C; Rech C; Jourdan C
    Arch Phys Med Rehabil; 2014 Jun; 95(6):1032-8. PubMed ID: 24407102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New approaches to managing spasticity in children with cerebral palsy.
    Im D; McDonald CM
    West J Med; 1997 Apr; 166(4):271. PubMed ID: 9168686
    [No Abstract]   [Full Text] [Related]  

  • 34. Intrathecal baclofen treatment in dystonic cerebral palsy: a randomized clinical trial: the IDYS trial.
    Bonouvrié LA; Becher JG; Vles JS; Boeschoten K; Soudant D; de Groot V; van Ouwerkerk WJ; Strijers R; Foncke E; Geytenbeek J; van de Ven PM; Teernstra O; Vermeulen RJ
    BMC Pediatr; 2013 Oct; 13():175. PubMed ID: 24165282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral baclofen increases maximal voluntary neuromuscular activation of ankle plantar flexors in children with spasticity due to cerebral palsy.
    van Doornik J; Kukke S; McGill K; Rose J; Sherman-Levine S; Sanger TD
    J Child Neurol; 2008 Jun; 23(6):635-9. PubMed ID: 18281622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of intrathecal baclofen on functional intelligibility of speech.
    Mason C; Gilpin P; McGowan S; Rossiter D
    Int J Lang Commun Disord; 1998; 33 Suppl():24-5. PubMed ID: 10343658
    [No Abstract]   [Full Text] [Related]  

  • 37. Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy.
    Albright AL; Barry MJ; Painter MJ; Shultz B
    J Neurosurg; 1998 Jan; 88(1):73-6. PubMed ID: 9420075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity.
    Bensmail D; Quera Salva MA; Roche N; Benyahia S; Bohic M; Denys P; Bussel B; Lofaso F
    Neurology; 2006 Oct; 67(8):1432-6. PubMed ID: 17060570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of clinical and neurophysiologic responses to intrathecal baclofen bolus administration in moderate-to-severe spasticity after acquired brain injury.
    Stokic DS; Yablon SA; Hayes A
    Arch Phys Med Rehabil; 2005 Sep; 86(9):1801-6. PubMed ID: 16181946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upper limbs function after intrathecal baclofen therapy in children with secondary dystonia.
    Motta F; Antonello CE; Stignani C
    J Pediatr Orthop; 2009; 29(7):817-21. PubMed ID: 20104168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.